Two Sigma Investments’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-268,007
Closed -$2.44M 3886
2025
Q2
$2.44M Sell
268,007
-90,378
-25% -$665K ﹤0.01% 1694
2025
Q1
$2.85M Buy
358,385
+228,635
+176% +$1.67M 0.01% 1502
2024
Q4
$705K Sell
129,750
-32,046
-20% -$196K ﹤0.01% 2369
2024
Q3
$1.17M Sell
161,796
-51,065
-24% -$468K ﹤0.01% 2034
2024
Q2
$2.31M Sell
212,861
-115,986
-35% -$1.49M 0.01% 1453
2024
Q1
$6.16M Buy
328,847
+79,875
+32% +$1.84M 0.01% 863
2023
Q4
$5.4M Buy
+248,972
New +$4.93M 0.01% 951
2023
Q3
Sell
-4,832
Closed -$227K 3180
2023
Q2
$227K Sell
4,832
-42,251
-90% -$2.1M ﹤0.01% 2607
2023
Q1
$1.98M Buy
47,083
+20,190
+75% +$868K 0.01% 1389
2022
Q4
$1.03M Sell
26,893
-109,960
-80% -$4.2M ﹤0.01% 1686
2022
Q3
$5.36M Sell
136,853
-39,172
-22% -$1.51M 0.02% 729
2022
Q2
$5.69M Buy
176,025
+169,706
+2,686% +$5.69M 0.02% 715
2022
Q1
$209K Buy
+6,319
New +$238K ﹤0.01% 2326
2021
Q2
Sell
-150,794
Closed -$11.3M 4493
2021
Q1
$11.3M Buy
150,794
+19,301
+15% +$1.58M 0.03% 654
2020
Q4
$11.4M Buy
131,493
+58,449
+80% +$4.31M 0.03% 554
2020
Q3
$4.46M Sell
73,044
-304,235
-81% -$15.4M 0.02% 848
2020
Q2
$15.7M Sell
377,279
-101,746
-21% -$3.69M 0.08% 271
2020
Q1
$13.8M Buy
479,025
+467,722
+4,138% +$27.1M 0.11% 185
2019
Q4
$816K Buy
+11,303
New +$1.39M ﹤0.01% 2380
2017
Q4
Sell
-90,596
Closed -$5.64M 3413
2017
Q3
$5.64M Buy
+90,596
New +$7.12M 0.02% 751
2015
Q3
Sell
-38,186
Closed -$2.79M 2659
2015
Q2
$2.79M Buy
+38,186
New +$2.45M 0.01% 1020

Other funds holding SAGE